- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Small Cap High Growth Stocks
Global Pharmaceuticals & Biotech Small Cap High Growth Stocks
UPDATED Nov 27, 2023
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
532 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| DBVDBV Technologies | €1.52 | -7.3% | -46.5% | €146.2m | €4.07 | PS28.8x | E50.0% | n/a | ||
| CAPRCapricor Therapeutics | US$2.99 | 0.7% | -24.1% | US$92.4m | US$13.50 | PS6.6x | E69.9% | n/a | ||
| OPTNOptiNose | US$1.20 | 0.8% | -31.4% | US$139.3m | US$3.00 | PS1.9x | E63.6% | n/a | ||
| URGNUroGen Pharma | US$12.78 | 2.8% | 56.4% | US$399.7m | US$39.00 | PS5.1x | E68.8% | n/a | ||
| ALDXAldeyra Therapeutics | US$2.62 | -1.5% | -49.6% | US$148.8m | US$10.40 | PB1.3x | E54.3% | n/a | ||
| AGRXAgile Therapeutics | US$2.08 | -1.9% | -79.1% | US$5.3m | US$8.50 | PE-0.4x | E76.2% | n/a | ||
| MGTXMeiraGTx Holdings | US$5.11 | -9.7% | -19.4% | US$344.7m | US$24.00 | PS48.6x | E61.3% | n/a | ||
| ENSCEnsysce Biosciences | US$0.84 | -6.5% | -97.6% | US$2.8m | US$12.25 | PB1.8x | E63.2% | n/a | ||
| LGPLittle Green Pharma | AU$0.12 | -4.0% | -33.3% | AU$37.5m | n/a | PS1.8x | E109.3% | n/a | ||
| 605177Zhejiang East Asia Pharmaceutical | CNÂ¥28.92 | 0.4% | 28.2% | CNÂ¥3.3b | n/a | PE25.5x | E30.5% | 1.0% | ||
| PIQProteomics International Laboratories | AU$0.92 | 4.5% | 7.6% | AU$112.5m | AU$2.42 | PS35.4x | E59.9% | n/a | ||
| ISABInhalation Sciences Sweden | kr4.54 | -8.7% | -11.7% | kr68.9m | kr17.00 | PS4.1x | E101.8% | n/a | ||
| HYLHyloris Pharmaceuticals | €12.60 | -0.8% | -9.0% | €352.8m | €19.90 | PS114.6x | E116.2% | n/a | ||
| MARIMarinomed Biotech | €35.00 | -10.0% | -47.8% | €53.2m | €66.53 | PS4.7x | E74.8% | n/a | ||
| AELISAelis Farma | €13.40 | 0% | 47.9% | €175.9m | €21.50 | PS17.9x | E29.2% | n/a | ||
| NICANanologica | kr10.20 | 3.7% | 1.0% | kr368.7m | kr14.75 | PS62.1x | E90.2% | n/a | ||
| CYCCCyclacel Pharmaceuticals | US$0.29 | -3.7% | -65.7% | US$3.9m | US$13.67 | PS9.4x | E33.3% | n/a | ||
| BSEMBioStem Technologies | US$3.26 | 8.7% | 8.7% | US$43.4m | US$9.25 | PS8.1x | E95.8% | n/a | ||
| CRMDCorMedix | US$3.65 | -3.4% | -11.8% | US$206.0m | US$14.25 | PS6733x | E62.3% | n/a | ||
| MDWDMediWound | US$8.56 | 0% | -23.6% | US$79.2m | US$28.00 | PS3.2x | E64.1% | n/a | ||
| ETONEton Pharmaceuticals | US$3.75 | 8.9% | 29.3% | US$96.2m | US$10.00 | PE43.1x | E137.9% | n/a | ||
| BFRIBiofrontera | US$3.21 | -5.0% | -84.6% | US$4.9m | US$20.00 | PB4.7x | E71.5% | n/a | ||
| CLGNCollPlant Biotechnologies | US$5.65 | 1.3% | 15.5% | US$71.0m | US$16.88 | PS6x | E38.3% | n/a | ||
| 4597Solasia Pharma K.K | JPÂ¥41.00 | 2.5% | -22.6% | JPÂ¥6.9b | JPÂ¥70.00 | PS5.7x | E72.5% | n/a |